Medipal HoldingsMAHLY 81 Shareholder Yield % is 3.98% as of Mar. 2026, which is 62% above its 10-year median of 2.45. GuruFocus rates MAHLY with a GF Score™ of 81/100 and a GF Value™ of $16.37 (Fairly Valued). The stock has 1 warning sign investors should review. Among 113 Medical Distribution companies, Medipal Holdings ranks better than 59.29% on this metric.
Shareholder Yield % is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. It is a measure of shareholder return.
As of today, Medipal Holdings's Shareholder Yield % was 3.98%.
Shareholder Yield % is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. The term was coined by William W. Priest of Epoch Investment Partners in a paper in 2005 entitled The Case for Shareholder Yield as a Dominant Driver of Future Equity Returns. William Priest indicated that "shareholder yield is a term that we came up with to reflect the various ways dividends can be paid to owners of a business in a publicly-traded company."
Dividend Yield % shows how much a company pays out in dividends each year relative to its stock price, which is most obvious form of shareholder return.
Buyback Yield % is the net repurchase of shares outstanding over the market capital of the company. Shares repurchases also increase shareholder value by returning the money back to shareholders.
Net Debt Paydown Yield % is the change in average of four quarters of company's total debt over a company's market cap. Assuming the total value of a company remains that same, shareholder value is increased as debt is reduced.
Medipal Holdings Shareholder Yield % Related Terms
Medipal Holdings Shareholder Yield % Historical Data
* Premium members only.
The historical data trend for Medipal Holdings's Shareholder Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MAHLY vs MCK, CAH, COR: Shareholder Yield % Comparison
For the Medical Distribution subindustry, Medipal Holdings's Shareholder Yield %, along with its competitors' market caps and Shareholder Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medipal Holdings Shareholder Yield % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Medipal Holdings's Shareholder Yield % distribution charts can be found below:
* The bar in red indicates where Medipal Holdings's Shareholder Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* All the data are calculated by TTM values. Note that if a companies is traded in several exchanges, then we calculate the company level data for Shareholder Yield % using the primary share class stock data. The calculation result in definition page is for demonstration purpose only, and it's showing the share class level data. Therefore, the numbers in the calculation may differ from elsewhere if the stock is not a primary share.
Medipal Holdings (MAHLY) has a Shareholder Yield % of 3.98% as of Mar. 2026. Shareholder Yield is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. View historical data on Medipal Holdings and its competitors. This is 62% above median its historical median of 2.45. According to the industry distribution chart, Medipal Holdings ranks #46 out of 113 companies in the Medical Distribution industry, placing it in the top 40.7%.
Is Medipal Holdings' Shareholder Yield % too high?
Medipal Holdings' current Shareholder Yield % of 3.98% is 62% above median its 10-year median of 2.45. The Medical Distribution industry median Shareholder Yield % is 2.49. Medipal Holdings' value of 3.98% is 59.8% above this industry median. Based on the distribution chart, Medipal Holdings ranks #46 out of 113 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, Medipal Holdings has a GF Score™ of 81/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Medipal Holdings' Shareholder Yield % compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Medipal Holdings ranks #46 out of 113 companies for Shareholder Yield %. This puts Medipal Holdings in the upper half of its industry. The industry median Shareholder Yield % is 2.49. Medipal Holdings' value of 3.98% is 59.8% above this benchmark. While the company's 10-year median is 2.45 vs. the industry median of 2.49, Medipal Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shareholder Yield % for a Medical Distribution company?
The median Shareholder Yield % among Medical Distribution companies is 2.49, based on 113 companies in the industry. Companies in the top quartile (top 25%) have a Shareholder Yield % significantly above this median, while those in the bottom quartile fall well below. However, Shareholder Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medipal Holdings's current Shareholder Yield % of 3.98% is 59.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shareholder Yield % mean?
A high Shareholder Yield % can signal that a stock is expensive relative to its fundamentals. Shareholder Yield is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. View historical data on Medipal Holdings and its competitors. For the Medical Distribution industry, the median Shareholder Yield % is 2.49 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medipal Holdings's current Shareholder Yield % is 3.98%, which is 62% above median its own 10-year median of 2.45. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medipal Holdings stock overvalued right now?
Based on GuruFocus' analysis, Medipal Holdings (MAHLY) is currently considered Fairly Valued. The stock's GF Value™ is $16.37, compared to a current price of $17.00 — trading 3.8% above its estimated fair value. The current Shareholder Yield % is 3.98%, which is 62% above median its 10-year median of 2.45 and 59.8% above the Medical Distribution industry median of 2.49. Medipal Holdings' overall GF Score™ is 81/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shareholder Yield % calculated?
Shareholder Yield % is calculated from a company's financial statements. For Medipal Holdings (MAHLY), the current Shareholder Yield % is 3.98% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medipal Holdings (MAHLY) Overvalued in 2026?
Based on GuruFocus' analysis, Medipal Holdings stock appears to be overvalued.
The current stock price of $17.00 is trading 3.8% above its estimated GF Value™ of $16.37.
GuruFocus considers Medipal Holdings to be Fairly Valued.
Key valuation signals for MAHLY:
Shareholder Yield %: 3.98% (62% above median its 10-year median of 2.45)
GF Value™: $16.37 vs. price of $17.00 (3.8% above fair value)
Industry Position: 59.8% above the Medical Distribution median (#46 of 113)
No single metric tells the full story. See the MAHLY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medipal Holdings Corp is engaged in the wholesale distribution of pharmaceuticals, cosmetics, daily necessities, and related products. The company operates through three reportable segments: Wholesale business of medical drugs; Cosmetics, Daily Necessities and OTC Pharmaceuticals Wholesale Business; and Wholesale of animal medicines and food processing ingredients. The Wholesale business of medical drugs segment targets hospitals, clinics, and dispensing pharmacies; the Cosmetics and OTC segment serves drug stores, home centers, convenience stores, and supermarkets; while the Wholesale of animal medicines and food processing ingredients segment supplies veterinary clinics, livestock and fisheries businesses, and food manufacturers.
81GF Score
Get the complete analysis for MAHLY
Shareholder Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MAHLY has been successfully added to your 
